No Data
No Data
Express News | Lipocine Inc: Lpcn 1154 Was Well Tolerated With No Sedation or Somnolence Events Observed
Express News | Lipocine Inc: On Track for Nda Filing, Targeted by End of Q4
Express News | Lipocine Inc: Lpcn 1154 Meets Bioequivalence With IV Brexanolone in Pivotal Study
Express News | Lipocine Says LPCN 1154 Met Standard Bioequivalence (BE) Criteria; Co Says On Track For NDA Filing, Targeting Q4 2024
Lipocine Announces LPCN 1154 Meets Bioequivalence With IV Brexanolone in Pivotal Study
Met standard bioequivalence (BE) criteria Cmax, AUC0-t, and AUC0-∞Ctrough criterion was metLPCN 1154 was well tolerated with no sedation or somnolence events observedOn track for NDA filing, targeted
12 Health Care Stocks Moving In Wednesday's Intraday Session
GainersGeovax Labs (NASDAQ:GOVX) stock moved upwards by 72.1% to $1.91 during Wednesday's regular session. The company's market cap stands at $4.8 million. Nexalin Technology (NASDAQ:NXL) shares incre
No Data
Jimmy1819 : have you been investing professionally or as a hobby?